Accelerate Diagnostics, Inc.
AXDX
$0.65
-$0.045-6.48%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 11.70M | 11.91M | 12.23M | 12.17M | 12.06M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 11.70M | 11.91M | 12.23M | 12.17M | 12.06M |
| Cost of Revenue | 8.99M | 9.02M | 10.09M | 9.91M | 9.51M |
| Gross Profit | 2.70M | 2.89M | 2.14M | 2.26M | 2.55M |
| SG&A Expenses | 21.33M | 22.51M | 24.64M | 26.82M | 31.22M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 47.01M | 50.02M | 56.38M | 60.29M | 66.09M |
| Operating Income | -35.31M | -38.11M | -44.14M | -48.12M | -54.03M |
| Income Before Tax | -50.11M | -52.89M | -37.21M | -58.20M | -60.77M |
| Income Tax Expenses | -66.00K | 564.00K | 695.00K | 851.00K | 851.00K |
| Earnings from Continuing Operations | -50.05 | -53.46 | -37.91 | -59.05 | -61.62 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -50.05M | -53.46M | -37.91M | -59.05M | -61.62M |
| EBIT | -35.31M | -38.11M | -44.14M | -48.12M | -54.03M |
| EBITDA | -31.89M | -34.68M | -40.77M | -44.81M | -50.77M |
| EPS Basic | -2.21 | -2.72 | -2.07 | -4.54 | -5.51 |
| Normalized Basic EPS | -1.46 | -1.06 | -1.51 | -2.28 | -2.88 |
| EPS Diluted | -2.21 | -2.72 | -2.07 | -4.54 | -5.51 |
| Normalized Diluted EPS | -1.46 | -1.06 | -1.51 | -2.28 | -2.88 |
| Average Basic Shares Outstanding | 92.40M | 81.77M | 71.28M | 59.24M | 49.85M |
| Average Diluted Shares Outstanding | 92.40M | 81.77M | 71.28M | 59.24M | 49.85M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
